ArticleMedical & biological engineering & computing2026
Study on the regulatory effect of magnetic vestibular stimulation on visually induced motion sickness.
Article in Medical & biological engineering & computing, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Visually induced motion sickness (VIMS) is a common adverse effect of virtual reality (VR). Magnetic vestibular stimulation (MVS) may modulate vestibular function, but its effect on VIMS remains unclear. This study examined whether different MVS intensities were associated with changes in VIMS symptoms and resting-state EEG network characteristics in healthy participants exposed to VR. Twenty healthy young adults completed five repeated-measures sessions: normal/non-VR, VR-only, and VR combined with MVS at 90%, 100%, and 110% of individual resting motor threshold (rMT). VIMS symptoms were assessed using the Simulator Sickness Questionnaire (SSQ) before and after each session. Resting-state EEG was recorded after each session, and brain functional network parameters were calculated across frequency bands. SSQ total and subscale scores differed significantly across sessions. Compared with VR alone, the 110% rMT condition showed a more favorable SSQ symptom profile, whereas 90% rMT MVS was associated with symptom aggravation. EEG network analysis showed exploratory session-related differences across multiple frequency bands, with the 110% rMT condition generally showing a pattern closer to baseline. In this study, higher-intensity MVS was associated with reduced VIMS symptoms, whereas lower-intensity MVS may worsen symptoms. These findings should be confirmed in larger studies.
Indexed as
Identifiers
42696245What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.